Elizabeth A. Ennis

Choline on the Move: Perspectives on the Molecular Physiology and Pharmacology of the Presynaptic Choline Transporter.

R. Blakely, E. Ennis, Randy D. Blakely, 2016, Advances in pharmacology.

Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium

Y. Sugiyama, K. Giacomini, S. Yee, 2018, Clinical pharmacology and therapeutics.

Synthesis and structure-activity relationships of a series of 4-methoxy-3-(piperidin-4-yl)oxy benzamides as novel inhibitors of the presynaptic choline transporter.

R. Blakely, C. Lindsley, C. Hopkins, 2015, Bioorganic & Medicinal Chemistry Letters.

Optimization of the choline transporter (CHT) inhibitor ML352: Development of VU6001221, an improved in vivo tool compound.

Anna L. Blobaum, R. Blakely, C. Lindsley, 2016, Bioorganic & medicinal chemistry letters.

Identification and Characterization of ML352: A Novel, Noncompetitive Inhibitor of the Presynaptic Choline Transporter

R. Blakely, O. McManus, C. Lindsley, 2015, ACS chemical neuroscience.

Nonoisotopic assay for the presynaptic choline transporter reveals capacity for allosteric modulation of choline uptake.

R. Blakely, Ericka C. Holmstrand, S. Ferguson, 2012, ACS chemical neuroscience.

Transgenic overexpression of the presynaptic choline transporter elevates acetylcholine levels and augments motor endurance

R. Blakely, M. Sarter, G. Stanwood, 2014, Neurochemistry International.